-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, major multinational pharmaceutical companies have successively announced their 2020 "transcripts.
Compared with 2019, the overall performance of the top ten multinational companies remains unchanged, but there are some differences in rankings.
It should be noted that the currency conversion of the ranking list is based on the real-time exchange rate on March 10.
TOP10 list of multinational pharmaceutical companies
Conversion unit: 1 euro ≈ 1.
The most surprising thing on the ranking this time is Pfizer.
According to the information released by Pfizer, the new crown vaccine jointly developed by Pfizer and BioNTech is expected to bring in $15 billion in revenue in 2021, or account for a quarter of the total revenue.
On the list, Bristol-Myers Squibb (BMS) and AbbVie have the most impressive growth rates in 2020, with the former increasing by 63% and the latter by more than 37%.
In June 2019, AbbVie acquired Allergan for US$63 billion.
In November 2019, BMS finally successfully included Xinji in the bag with 74 billion US dollars.
Pharmaceutical business revenue TOP10
Conversion unit: 1 euro ≈ 1.
In terms of pharmaceutical business revenue, compared with 2019, the TOP10 ranking has changed significantly.
Affected by mergers and acquisitions, AbbVie has become the top three companies in the pharmaceutical business revenue.
Top 10 best-selling drugs in the world
Conversion unit: 1 euro ≈ 1.
It is worth mentioning that AbbVie's Humira will continue to perform well in 2020.
Affected by the acquisition of Xinji, BMS owns the anti-tumor drug Revlimid developed by the former, and its sales volume in 2020 ranks third in the world.
Revenue ranking of multinational pharmaceutical companies in China
Conversion unit: 1 euro ≈ 1.
Judging from the existing data, despite the impact of the epidemic in 2020 and the price cuts of medical insurance negotiations, China is still the target market for multinational pharmaceutical companies to continue to increase.
Except Sanofi, other multinational pharmaceutical companies have an average revenue in China.
With different degrees of improvement, AstraZeneca is still the "king.
"
